Juno Pharmaceuticals
Juno Pharmaceuticals LP is an Australian private pharmaceutical company that manufactured and distributed generic and specialty medications including amoxicillin, hydromorphone, and phentermine, primarily serving the Australian market through its Juno OTC brand.
- Company typePrivate
- Founded2012
- HeadquartersCremorne, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Juno Pharmaceuticals firmographics
Firmographics- Name
- Juno Pharmaceuticals
- Legal name
- Juno Pharmaceuticals LP
- Website
- https://junopharm.com.au
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Juno Pharmaceuticals LP is an Australian private pharmaceutical company that manufactured and distributed generic and specialty medications including amoxicillin, hydromorphone, and phentermine, primarily serving the Australian market through its Juno OTC brand.
- Ownership category
- akta.pro rank
Juno Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
Keywords
Where Juno Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Cremorne
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Juno Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Juno Pharmaceuticals product offering
Product offeringCore offering
Juno Pharmaceuticals LP manufactures and distributes generic pharmaceutical products for the Australian market, including amoxicillin, hydrochloride syringes, hydromorphone solutions, and phentermine tablets and capsules. The company also operated an over-the-counter product line under the Juno OTC brand, which was divested to LSL Pharma Group in December 2025. Its customer base comprises pharmaceutical wholesalers, pharmacies, and healthcare providers.
Differentiator
Problem solved
Functional benefit
Products and services
- Amoxicillin
- Hydrochloride Syringes
- Hydromorphone Solutions
- Phentermine Tablets and Capsules
- Juno OTC
Companies that use Juno Pharmaceuticals
Customer profileIdeal customer profiles1 record
Juno Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Juno Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- LSL Pharma Group Inc.unclearLSL Pharma Group acquired Juno OTC Inc. from Juno Pharmaceuticals LP for $5 million total purchase price ($2.5M cash, 5,509,642 Class A shares, $500K deferred). Transaction closed December 23, 2025. Juno Pharmaceuticals retained operational control through December 31, 2025.
Scale indicators1 record
Juno Pharmaceuticals competitors and assessment
Company assessmentMarket position
Customer concentration
Juno Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Juno Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
Juno Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Juno Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Juno Pharmaceuticals
What does Juno Pharmaceuticals do?
Juno Pharmaceuticals LP manufactures and distributes generic pharmaceutical products for the Australian market, including amoxicillin, hydrochloride syringes, hydromorphone solutions, and phentermine tablets and capsules. The company also operated an over-the-counter product line under the Juno OTC brand, which was divested to LSL Pharma Group in December 2025. Its customer base comprises pharmaceutical wholesalers, pharmacies, and healthcare providers.
Is Juno Pharmaceuticals a public or private company?
Juno Pharmaceuticals is a private company. It is classified as venture growth investor backed and is currently operating.
When was Juno Pharmaceuticals founded?
Juno Pharmaceuticals was founded in 2012. It employs 11 to 50 people.
Where is Juno Pharmaceuticals based?
Juno Pharmaceuticals is headquartered in Cremorne, Australia, in the Oceania region.
Does Juno Pharmaceuticals have an API?
No public API is recorded for Juno Pharmaceuticals.
What industry is Juno Pharmaceuticals in?
Juno Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 424210 and its SIC code is 5122.